Gongcheng Ma

Gongcheng Ma

Auto-generated profile, based on publicly available information

Gongcheng Ma

Guangdong Key Laboratory of Nanomedicine Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations CAS-HK Joint Lab for Biomaterials Research Laboratory for Biomedical Optics and Molecular Imaging Shenzhen Key Laboratory for Molecular Imaging CAS Key Lab for Health Informatics Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
GMGongcheng Ma
Gongcheng Ma
ZLZhongke Liu
Zhongke Liu
CZChunguang Zhu
Chunguang Zhu
HCHuajie Chen
Huajie Chen
RKRyan Tsz Kin Kwok
Ryan Tsz Kin Kwok
PGPing Gong
Ping Gong

29 July 2022 in Angewandte Chemie
Verified
Journal Article
Closed access
GMGongcheng Ma
Gongcheng Ma
ZLZhongke Liu
Zhongke Liu
CZChunguang Zhu
Chunguang Zhu
HCHuajie Chen
Huajie Chen
RKRyan Tsz Kin Kwok
Ryan Tsz Kin Kwok
PGPing Gong
Ping Gong

15 August 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
GMGongcheng Ma
Gongcheng Ma
NZNan Zhang
Nan Zhang
HSHongrong Shi
Hongrong Shi
YLYaoqiang Li
Yaoqiang Li
HWHaoran Wang
Haoran Wang
QDQihang Ding
Qihang Ding
The clinical efficacy of photodynamic therapy (PDT) is fundamentally limited by the scarcity of efficient photosensitizers (PSs) and the oxygen dependence of singlet‐oxygen–mediated cytotoxicity. Here we report pentaperylene decaimide selenide (PPD‐Se), a nanographene‐derived photoelectronic material that functions as a high‐performance Type‐II photosensitizer. PPD‐Se exhibits broadband absorption (300–650 nm), enhanced intersystem crossing enabled by a selenium‐induced heavy‐atom effect, a small ΔE ST (0.50 eV), and a high 1 O 2 quantum yield ( Φ Δ = 0.40). To address hypoxia‐limited PDT, PPD‐Se nanoparticles were covalently integrated with microalgae to construct an algae@PPD‐Se biohybrid, in which PPD‐Se is shielded from premature activation yet undergoes glutathione (GSH)‐triggered release in the tumor microenvironment. Cleavage of disulfide linkages restores the photosynthetic activity of algae, enabling light‐driven O 2 production that alleviates local hypoxia and simultaneously boosts PPD‐Se‐mediated ROS generation. The biohybrid exhibits enhanced intracellular uptake, amplified ROS production, and potent apoptosis induction under white light‐emitting diode (LED) irradiation (400–700 nm, 1 mW·cm −2 ). In vivo, algae@PPD‐Se significantly downregulates HIF‐1α, restores intra‐tumoral oxygenation, and achieves marked tumor growth inhibition without observable systemic toxicity. This study introduces a dual‐functional optoelectronic‐biological PDT platform that couples a newly designed nanographene photosensitizer with photosynthetic oxygenation, offering a mechanistically driven strategy to overcome the oxygen dependency of PDT.